The MOMENTUS  Readiness Platform

The MOMENTUS  Readiness Platform supports assets from proof of concept to regulatory approval, providing strategic insights, targeted recommendations, and evidence-generation platforms and plans designed to meet the dynamic needs of prescribers, payers, and patients.

ASSET DEVELOPMENT
Today’s innovators must develop their science with the commercial end in mind. We ensure a well-informed clinical development and regulatory strategy that incorporates the needs of prescribers, payers, and patients. Via our team of clinical trial experts, we optimize the value of your asset and the path from proof of concept to regulatory approval.

STRATEGIC ACCELERATION WITH MOMENTUS AI
MOMENTUS AI is a strategic approach that blends deep consulting expertise with advanced AI to drive smarter, faster decisions in healthcare. It empowers our experts to proactively shape strategies, accelerate new technology adoption, and deliver high-impact outcomes across clinical development, regulatory, commercial and market access.

COMMERCIAL LAUNCH READINESS
Our consultants are industry-experienced brand leaders and new product planners who seamlessly bridge clients from early asset development to commercial launch. Offering proven strategic guidance for portfolio strategy, lifecycle indication planning, brand planning, and pricing & reimbursement, we ensure a patient-centric commercial strategy to optimize launch and marketplace success.

EVIDENCE GENERATION
Pivotal trials, no matter how well designed for market realities, do not mark the end of the readiness journey. Continued success requires proactive real world data generation and economic analyses that matter to key stakeholders. Our holistic and integrated evidence planning platform enables the prioritization and execution of the right evidence for the right audience – prescriber, organized provider and payer.

THOUGHT LEADERSHIP
MOMENTUS Perspective is our thought leadership platform exploring the forces shaping biopharma and healthcare. Through expert insights across policy, market access, value and pricing, and emerging applications of AI, we examine, and offer our opinions how strategy, evidence, and innovation converge to support smarter decisions across the product lifecycle.

Why?
Industry transformation and regulatory complexity require a need for targeted insights and strategies.

What?
Strategic expertise and operational support across business, clinical, and commercial functions.

Together.
We can accelerate the approval and adoption of life-changing therapies for patients.

Contact US

John “Zeke” Czekanski
CEO / Managing Partner
zeke@momentusbioconsulting.com

Scott Roberts
Chief Strategy Officer / Managing Partner
scott.roberts@momentusbioconsulting.com